Trial Profile
A Phase II trial evaluating efficacy of Mydayis in adolescents patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2017
Price :
$35
*
At a glance
- Drugs Mixed amfetamine salts (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 28 Jun 2017 New trial record
- 20 Jun 2017 Results published in the Shire Media Release